The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide

  1. Serrano Domingo, J.J.
  2. Alonso Gordoa, T.
  3. Lorca Álvaro, J.
  4. Molina-Cerrillo, J.
  5. Barquín García, A.
  6. Martínez Sáez, O.
  7. Burgos Revilla, J.
  8. Carrato, A.
  9. Álvarez Rodríguez, S.
Revista:
Therapeutic Advances in Urology

ISSN: 1756-2880 1756-2872

Any de publicació: 2021

Volum: 13

Tipus: Article

DOI: 10.1177/17562872211043341 GOOGLE SCHOLAR lock_openAccés obert editor